Reuters logo
BRIEF-Conatus Pharmaceuticals issued a convertible promissory note of $15 mln to Novartis Pharma AG pursuant to investment agreement entered in Dec 2016
February 16, 2017 / 10:41 PM / 8 months ago

BRIEF-Conatus Pharmaceuticals issued a convertible promissory note of $15 mln to Novartis Pharma AG pursuant to investment agreement entered in Dec 2016

Feb 16 (Reuters) - Conatus Pharmaceuticals Inc

* Conatus Pharmaceuticals - On Feb 15, co issued a convertible promissory note of $15 million to Novartis Pharma AG pursuant to investment agreement entered in Dec 2016 Source text: [bit.ly/2lpeTOz] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below